Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

NCT06672146 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

93

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DRUG: Decitabine and Cedazuridine
DRUG: Enasidenib
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)